NTRB

Nutriband (NTRB)

About Nutriband (NTRB)

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.

Details

Daily high
$6.94
Daily low
$6.21
Price at open
$6.22
52 Week High
$9.60
52 Week Low
$1.53
Market cap
69.6M
Dividend yield
0.00%
Volume
34,156
Avg. volume
47,298
P/E ratio
-7.69

Nutriband News

Details

Daily high
$6.94
Daily low
$6.21
Price at open
$6.22
52 Week High
$9.60
52 Week Low
$1.53
Market cap
69.6M
Dividend yield
0.00%
Volume
34,156
Avg. volume
47,298
P/E ratio
-7.69